NCT01340157View on ClinicalTrials.gov

Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
PK in Healthy Volunteers
Interventions
DRUG

Fexinidazole

Single oral dose of 1200mg fexinidazole consisting of 2 tablets dosed at 600mg per tablet.

Trial Locations (1)

75015

SGS Aster s.a.s., Paris

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Drugs for Neglected Diseases

OTHER

NCT01340157 - Fexinidazole (1200mg) Bioavailability Under Different Food Intake Conditions | Biotech Hunter | Biotech Hunter